As of today, intrinsic value of United Therapeutics Corporation is $384.1.
As of today, United Therapeutics Corporation is undervalued by 3.7%, compared to the current market share price of $370.5.
As of today, United Therapeutics Corporation has a stock rating of 6 (out of 10), which is considered Good.
As of today, United Therapeutics Corporation has a Good stock rating, which is 3.7% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.